HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kumar P Chandra Selected Research

3- ((2- (methylsulfonyl)hydrazino)carbonyl)- 1- (2- oxo- 2- thienylethyl)pyridinium

1/2009Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kumar P Chandra Research Topics

Disease

1Diabetes Mellitus
01/2009
1Diabetes Complications
01/2009

Drug/Important Bio-Agent (IBA)

13- ((2- (methylsulfonyl)hydrazino)carbonyl)- 1- (2- oxo- 2- thienylethyl)pyridiniumIBA
01/2009
1Ethyl Chloride (Chloroethane)IBA
01/2009
1Advanced Glycation End ProductsIBA
01/2009